|
Volumn 112, Issue 6, 2013, Pages 852-853
|
Modulating the immune response to Bacillus Calmette-Guérin (BCG): A novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
BETA DEFENSIN 2;
ADAPTIVE IMMUNITY;
ARTICLE;
BLADDER CANCER;
CANCER CELL;
CANCER IMMUNOTHERAPY;
DOSE RESPONSE;
DRUG EFFICACY;
HUMAN;
INNATE IMMUNITY;
INTERNALIZATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
BCG VACCINE;
CARCINOMA, TRANSITIONAL CELL;
HUMANS;
IMMUNITY, CELLULAR;
MYCOBACTERIUM BOVIS;
URINARY BLADDER NEOPLASMS;
|
EID: 84884251039
PISSN: 14644096
EISSN: 1464410X
Source Type: Journal
DOI: 10.1111/bju.12261 Document Type: Article |
Times cited : (9)
|
References (7)
|